CopyFind
药品 📍 BR

VILDAGLIPTINA + CLORIDRATO DE METFORMINA

77,35 R$

Max. consumer price (CMED)

Analogs of VILDAGLIPTINA + CLORIDRATO DE METFORMINA

Find cheaper analogs and generic equivalents for VILDAGLIPTINA + CLORIDRATO DE METFORMINA.

Ingredients

活性成分: vildagliptine, metformine hydrochloride


产品概览

About VILDAGLIPTINA + CLORIDRATO DE METFORMINA

VILDAGLIPTINA + CLORIDRATO DE METFORMINA is a medication containing the active ingredient Vildagliptin. Vildagliptin, sold under the brand name Galvus among others, is an oral anti-hyperglycemic agent of the dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Vildagliptin inhibits the inactivation of GLP-1 and GIP by DPP-4, allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta cells and suppress….

Key Benefits & Uses

  • Used for: Vildagliptin, sold under the brand name Galvus among others, is an oral anti-hyperglycemic agent of the dipeptidyl peptidase-4 (DPP-4) inhibitor.
  • Used for: Vildagliptin inhibits the inactivation of GLP-1 and GIP by DPP-4, allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta cells and.
  • Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Vildagliptin, the active ingredient in VILDAGLIPTINA + CLORIDRATO DE METFORMINA, is the pharmacologically active substance of this product. Its clinical use follows the authorised labelling for Vildagliptin-containing medicines. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking VILDAGLIPTINA + CLORIDRATO DE METFORMINA. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use VILDAGLIPTINA + CLORIDRATO DE METFORMINA for extended periods without medical advice.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.